Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2009 1
2010 2
2013 1
2014 3
2015 2
2016 2
2017 3
2018 3
2019 3
2020 11
2021 12
2022 8
2023 7
2024 5
2025 12
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, d'Incan M, Ingen-Housz-Oro S, Orvain C, Abraham J, Dereure O, Charbonnier A, Cornillon J, Longvert C, Barete S, Boulinguez S, Wierzbicka-Hainaut E, Aubin F, Rubio MT, Bernard M, Schmidt-Tanguy A, Houot R, Pham-Ledard A, Michonneau D, Brice P, Labussière-Wallet H, Bouaziz JD, Grange F, Moins-Teisserenc H, Jondeau K, Michel L, Mourah S, Battistella M, Daguindau E, Loschi M, Picard A, Franck N, Maillard N, Huynh A, Nguyen S, Marçais A, Chaby G, Ceballos P, Le Corre Y, Maury S, Bay JO, Adamski H, Bachy E, Forcade E, Socié G, Bagot M, Chevret S, Peffault de Latour R; CUTALLO Investigators; Groupe Français d'Etude des Lymphomes Cutanés; Société Française de Greffe de Moëlle et Thérapie Cellulaire. de Masson A, et al. Among authors: ceballos p. Lancet. 2023 Jun 10;401(10392):1941-1950. doi: 10.1016/S0140-6736(23)00329-X. Epub 2023 Apr 24. Lancet. 2023. PMID: 37105210
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Chevallier P, Leguay T, Delord M, Salek C, Kim R, Huguet F, Hicheri Y, Wartiovaara-Kautto U, Raffoux E, Cluzeau T, Balsat M, Roth-Guepin G, Tavernier E, Lepretre S, Bilger K, Bergugnat H, Berceanu A, Alexis M, Doubek M, Brissot E, Hunault-Berger M, Lebon D, Turlure P, Chantepie S, Belhabri A, Wickenhauser S, Bastie JN, Cacheux V, Himberlin C, Banos A, Gardin C, Bonnet S, Plantier I, Pica GM, Escoffre-Barbe M, Boissel N, Dombret H, Clappier E, Rousselot P; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) and the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL). Chevallier P, et al. J Clin Oncol. 2024 Dec 20;42(36):4327-4341. doi: 10.1200/JCO.24.00490. Epub 2024 Oct 17. J Clin Oncol. 2024. PMID: 39418626 Clinical Trial.
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.
de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, Rouanet J, Ingen-Housz-Oro S, Orvain C, Abraham J, Dereure O, Charbonnier A, Cornillon J, Longvert C, Barete S, Boulinguez S, Wierzbicka-Hainaut E, Aubin F, Rubio MT, Bernard M, Schmidt-Tanguy A, Houot R, Pham-Ledard A, Michonneau D, Labussière-Wallet H, Bouaziz JD, Grange F, Moins-Teisserenc H, Jondeau K, Mourah S, Battistella M, Daguindau E, Loschi M, Picard A, Franck N, Maillard N, Huynh A, Nguyen S, Marçais A, Chaby G, Ceballos P, Le Corre Y, Maury S, Bay JO, Adamski H, Bachy E, Forcade E, Socié G, Bagot M, Chevret S, Peffault de Latour R; CUTALLO Investigators, Groupe Français d’Etude des Lymphomes Cutanés and Société Française de Greffe de Moëlle et Thérapie Cellulaire. de Masson A, et al. Among authors: ceballos p. J Clin Oncol. 2025 Aug;43(22):2461-2466. doi: 10.1200/JCO-25-00183. Epub 2025 Jun 13. J Clin Oncol. 2025. PMID: 40513043 Free article.
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Brissot E, Labopin M, Labussière H, Fossard G, Chevallier P, Guillaume T, Yakoub-Agha I, Srour M, Bulabois CE, Huynh A, Chantepie S, Menard AL, Rubio MT, Ceballos P, Dulery R, Furst S, Malard F, Blaise D, Mohty M. Brissot E, et al. Among authors: ceballos p. Blood Cancer J. 2024 Feb 19;14(1):31. doi: 10.1038/s41408-024-00990-3. Blood Cancer J. 2024. PMID: 38374026 Free PMC article. Clinical Trial.
Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder.
Yska HAF, Golse M, Beerepoot S, Hayer S, Bergner C, de Paiva ARB, Marelli C, Palacios NJ, Osorio YL, Huiban C, Franke G, Wortmann F, Holtick U, Ayrignac X, van der Knaap MS, Schöls L, Perlbarg V, Galanaud D, de Witte MA, Wolf NI, Nguyen S, Mochel F; and the International CSF1R‐RD Working Group. Yska HAF, et al. Mov Disord. 2025 Sep;40(9):1826-1835. doi: 10.1002/mds.30282. Epub 2025 Jul 11. Mov Disord. 2025. PMID: 40646711 Free PMC article.
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT.
Güven M, Peczynski C, Boreland W, Blaise D, Peffault de Latour R, Yakoub-Agha I, Gedde-Dahl T, Salmenniemi U, Forcade E, Passweg J, Chevallier P, Sandrine L, Mielke S, Broers A, Ceballos P, Byrne J, Castilla-Llorente C, Maertens J, Huynh A, Cerretti R, Bulabois CE, van Gorkom G, Crawley C, Graham C, Mussetti A, Schoemans H, Penack O, Moiseev I, Peric Z. Güven M, et al. Among authors: ceballos p. Bone Marrow Transplant. 2025 Jul;60(7):956-963. doi: 10.1038/s41409-025-02580-8. Epub 2025 Apr 17. Bone Marrow Transplant. 2025. PMID: 40246943
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party.
Villalba M, Ferhat AT, Gedde-Dahl T, Socie G, Huynh A, Blau IW, Yakoub-Agha I, Blaise D, Eder M, Forcade E, Fanin R, Passweg J, Crawley C, Stelljes M, Stölzel F, Kroeger N, Sengeloev H, Ceballos P, Labussiere-Wallet H, Poiré X, Esteve J, Savani B, Nagler A, Piemontese S, Sanz J, Mohty M, Ciceri F. Villalba M, et al. Among authors: ceballos p. Bone Marrow Transplant. 2026 Feb;61(2):187-196. doi: 10.1038/s41409-025-02751-7. Epub 2025 Nov 29. Bone Marrow Transplant. 2026. PMID: 41318843
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.
Dachy G, Labopin M, Socié G, Castilla-Llorente C, Forcade E, Blau IW, Ceballos P, Deconinck E, Burns D, Bulabois CE, Vrhovac R, Huynh A, Blaise D, Maertens J, Schroeder T, Bay JO, Savani B, Spyridonidis A, Ciceri F, Mohty M. Dachy G, et al. Among authors: ceballos p. Bone Marrow Transplant. 2025 Sep;60(9):1258-1264. doi: 10.1038/s41409-025-02614-1. Epub 2025 Jun 19. Bone Marrow Transplant. 2025. PMID: 40537507
64 results